Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2019

01-07-2019 | Chronic Pancreatitis | Editorial

Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: True Association or EPIphenomenon?

Authors: Salmaan Jawaid, Chris E. Forsmark

Published in: Digestive Diseases and Sciences | Issue 7/2019

Login to get access

Excerpt

Exocrine pancreatic insufficiency (EPI) is caused by inadequate delivery of pancreatic digestive enzymes to the intestinal lumen, leading to maldigestion. While longstanding chronic pancreatitis (CP) is the most well-known cause, EPI is also very common in patients with pancreatic malignancy, and in those who have undergone pancreatic resection for benign or malignant disease. Less commonly known are a number of additional conditions, which may also have EPI as a consequence (Table 1). One such condition is acute pancreatitis. While clinicians might recognize that EPI could develop after an episode of severe acute pancreatitis (AP) associated with significant pancreatic necrosis, it is becoming more apparent that EPI may occur even in those with less severe episodes of AP. The systematic review and meta-analysis published in this issue of Digestive Diseases and Sciences [1] provide an estimate of the prevalence and predictors of EPI after AP.
Table 1
Some of the causes of exocrine pancreatic insufficiency
Etiology
Frequency of EPI
Comments
Chronic pancreatitis
Dependent on etiology and duration of disease. Occurs in 30–50%
Usually requires loss of 90% of exocrine enzyme secretion. Most common in chronic pancreatitis due to genetic causes, alcohol, autoimmune, or smoking
Cystic fibrosis
Nearly universal, from birth
 
Pancreatic cancer
50–90%, depending on location
Most frequent with cancer of head of pancreas, with pancreatic ductal obstruction
Pancreatic resection
Variable depending on operation
Most common with larger resections, most common after Whipple resection
Asynchrony after GI surgery
Roux-en-Y surgeries most common, including gastric bypass
While pancreatic enzyme secretion may be normal, inadequate mixing with food can cause maldigestion
Shwachman–Diamond and Johanson–Blizzard
EPI very common, but diseases are rare
Genetic syndromes usually detected in childhood
Acute pancreatitis
More common with more extensive necrosis and those with alcohol or smoking as etiologies
Can occur even in the absence of necrosis, and may persist
Diabetes
Reduced fecal elastase common, but EPI rare
Longstanding diabetes may produce pancreatic damage similar to chronic pancreatitis, termed “diabetic pancreatopathy”
Zollinger–Ellison syndrome
EPI common, but condition quite rare
Acid denaturation of pancreatic enzymes
Literature
2.
go back to reference Hollemans R, Hall NDL, Mager DJ, et al. Pancreatic exocrine insufficiency following acute pancreatitis: systematic review and study level meta-analysis. Pancreatology. 2018;18:253–263.CrossRefPubMed Hollemans R, Hall NDL, Mager DJ, et al. Pancreatic exocrine insufficiency following acute pancreatitis: systematic review and study level meta-analysis. Pancreatology. 2018;18:253–263.CrossRefPubMed
3.
go back to reference Murtaugh LC, Keefe MD. Regeneration and repair of the exocrine pancreas. Annu Rev Physiol. 2015;77:229–249.CrossRefPubMed Murtaugh LC, Keefe MD. Regeneration and repair of the exocrine pancreas. Annu Rev Physiol. 2015;77:229–249.CrossRefPubMed
5.
go back to reference Bartel MJ, Asbun H, Stauffer J, Raimondo M. Pancreatic exocrine insufficiency in pancreatic cancer: a review of the literature. Dig Liver Dis. 2015;47:1013–1020.CrossRefPubMed Bartel MJ, Asbun H, Stauffer J, Raimondo M. Pancreatic exocrine insufficiency in pancreatic cancer: a review of the literature. Dig Liver Dis. 2015;47:1013–1020.CrossRefPubMed
6.
go back to reference Sand J, Nordback I. Acute pancreatitis: risk of recurrence and late consequences of the disease. Nat Rev Gastroenterol Hepatol. 2009;6:470–477.CrossRefPubMed Sand J, Nordback I. Acute pancreatitis: risk of recurrence and late consequences of the disease. Nat Rev Gastroenterol Hepatol. 2009;6:470–477.CrossRefPubMed
8.
go back to reference Dominguez-Munoz JE, Hardt P, Lerch MM, Lohr MJ. Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test. Dig Dis Sci. 2017;62:1119–1130.CrossRefPubMed Dominguez-Munoz JE, Hardt P, Lerch MM, Lohr MJ. Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test. Dig Dis Sci. 2017;62:1119–1130.CrossRefPubMed
10.
go back to reference Duggan S, O’Sullivan M, Feehan S, Ridgway P, Conlon K. Nutrition treatment of deficiency and malnutrition in chronic pancreatitis: a review. Nutr Clin Pract. 2010;25:362–370.CrossRefPubMed Duggan S, O’Sullivan M, Feehan S, Ridgway P, Conlon K. Nutrition treatment of deficiency and malnutrition in chronic pancreatitis: a review. Nutr Clin Pract. 2010;25:362–370.CrossRefPubMed
11.
go back to reference Duggan SN, Smyth ND, Murphy A, MacNaughton D, O’Keefe SJD, Conlon KC. High prevalence of osteoporosis in patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:219–228.CrossRefPubMed Duggan SN, Smyth ND, Murphy A, MacNaughton D, O’Keefe SJD, Conlon KC. High prevalence of osteoporosis in patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:219–228.CrossRefPubMed
12.
go back to reference de la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, et al. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis. J Clin Gastroenterol. 2018;52(8):e63–e72.CrossRefPubMed de la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, et al. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis. J Clin Gastroenterol. 2018;52(8):e63–e72.CrossRefPubMed
14.
go back to reference Sabater L, Ausania F, Bakker OJ, et al. Evidence-based guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery. Ann Surg. 2016;264:949–958.CrossRefPubMed Sabater L, Ausania F, Bakker OJ, et al. Evidence-based guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery. Ann Surg. 2016;264:949–958.CrossRefPubMed
15.
go back to reference Forsmark CE, Tang G, Tuft M, et al. Oral pancreatic enzyme replacement therapy (PERT) in patients with pancreatic cancer (PCa) is infrequent and suboptimal: a national level analysis (abstract). Pancreas. 2017;46:1400. Forsmark CE, Tang G, Tuft M, et al. Oral pancreatic enzyme replacement therapy (PERT) in patients with pancreatic cancer (PCa) is infrequent and suboptimal: a national level analysis (abstract). Pancreas. 2017;46:1400.
Metadata
Title
Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: True Association or EPIphenomenon?
Authors
Salmaan Jawaid
Chris E. Forsmark
Publication date
01-07-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05653-z

Other articles of this Issue 7/2019

Digestive Diseases and Sciences 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.